Grampovnik; David J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Grampovnik; David J..The latest application filed is for "hiv protease inhibiting compounds".
- Grampovnik; David J. - Waukegan IL
| Patent | Date |
|---|---|
| Macrocyclic hepatitis C serine protease inhibitors Grant 9,309,279 - Ku , et al. April 12, 2 | 2016-04-12 |
| Phenanthridine macrocyclic hepatitis C serine protease inhibitors Grant 8,951,964 - McDaniel , et al. February 10, 2 | 2015-02-10 |
| HIV Protease Inhibiting Compounds App 20140194349 - DeGoey; David A. ; et al. | 2014-07-10 |
| Macrocyclic Hepatitis C Serine Protease Inhibitors App 20140148573 - Ku; Yiyin ; et al. | 2014-05-29 |
| HIV protease inhibiting compounds Grant 8,653,141 - Flentge , et al. February 18, 2 | 2014-02-18 |
| Macrocyclic hepatitis C serine protease inhibitors Grant 8,642,538 - Ku , et al. February 4, 2 | 2014-02-04 |
| Prodrugs of HIV protease inhibitors Grant 8,426,388 - DeGoey , et al. April 23, 2 | 2013-04-23 |
| Macrocyclic hepatitis C serine protease inhibitors Grant 8,420,596 - Ku , et al. April 16, 2 | 2013-04-16 |
| Hiv Protease Inhibiting Compounds App 20130023463 - Flentge; Charles A. ; et al. | 2013-01-24 |
| Phenanthridine Macrocyclic Hepatitis C Serine Protease Inhibitors App 20120295842 - McDaniel; Keith F. ; et al. | 2012-11-22 |
| Macrocyclic Hepatitis C Serine Protease Inhibitors App 20120196792 - Ku; Yiyin ; et al. | 2012-08-02 |
| HIV protease inhibiting compounds Grant 8,193,227 - Flentge , et al. June 5, 2 | 2012-06-05 |
| Anti-viral compounds Grant 7,915,411 - Betebenner , et al. March 29, 2 | 2011-03-29 |
| Anti-viral compounds Grant 7,910,595 - Betebenner , et al. March 22, 2 | 2011-03-22 |
| HIV protease inhibiting compounds App 20110003827 - Flentge; Charles A. ; et al. | 2011-01-06 |
| HIV protease inhibiting compounds Grant 7,834,043 - DeGoey , et al. November 16, 2 | 2010-11-16 |
| Prodrugs Of Hiv Protease Inhibitors App 20100286032 - DeGoey; David A. ; et al. | 2010-11-11 |
| HIV Protease Inhibiting Compounds App 20100249181 - DeGoey; David A. ; et al. | 2010-09-30 |
| Macrocyclic hepatitis C serine protease inhibitors App 20100144608 - Ku; Yiyin ; et al. | 2010-06-10 |
| Prodrugs of HIV protease inhibitors Grant 7,718,633 - DeGoey , et al. May 18, 2 | 2010-05-18 |
| HIV protease inhibiting compounds Grant 7,696,226 - Randolph , et al. April 13, 2 | 2010-04-13 |
| Prodrugs of HIV protease inhibitors App 20070270383 - DeGoey; David A. ; et al. | 2007-11-22 |
| Anti-viral Compounds App 20070232627 - Betebenner; David A. ; et al. | 2007-10-04 |
| Anti-viral Compounds App 20070197558 - Betebenner; David A. ; et al. | 2007-08-23 |
| HIV protease inhibiting compounds App 20050159469 - Randolph, John T. ; et al. | 2005-07-21 |
| HIV protease inhibiting compounds App 20050148623 - DeGoey, David A. ; et al. | 2005-07-07 |
| HIV protease inhibiting compounds App 20050131017 - DeGoey, David A. ; et al. | 2005-06-16 |
| HIV protease inhibiting compounds App 20050131042 - Flentge, Charles A. ; et al. | 2005-06-16 |
| Inhibitors of neuraminidases Grant 6,831,096 - Maring , et al. December 14, 2 | 2004-12-14 |
| Inhibitors of neuraminidases App 20040097471 - Maring, Clarence J. ; et al. | 2004-05-20 |
| Inhibitors of neuraminidases Grant 6,455,571 - Maring , et al. September 24, 2 | 2002-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 